Despite critics, Chinese medicine to gain WHO acceptance

Despite critics, Chinese medicine to gain WHO acceptance
Shutterstock
A man measures ingredients in traditional Asian apothecary.

Herbal remedies have been used by healers around the world for centuries to prevent and treat disease. But it’s in China that the practice has been most extensively used and documented.

Advocates have campaigned to integrate Traditional Chinese Medicine into mainstream global health care and those long-standing TCM efforts have paid off: The World Health Assembly, the governing body of the World Health Organization, on Saturday formally approved the latest version of its influential global compendium, which includes a chapter on traditional medicine for the first time.

However, not everybody is happy with the controversial move. Some in the biomedical community say WHO overlooked the toxicity of some herbal medicine and the lack of evidence it works, while animal rights advocates say it will further endanger animals such as the tiger, pangolin, bear and rhino, whose organs are used in some TCM cures.

In a strongly worded editorial, Scientific American magazine called the move “an egregious lapse in evidence-based thinking and practice.”

Dr. Arthur Grollman, a professor of pharmacological science and medicine at Stony Brook University in New York, agrees with this assessment. “It will confer legitimacy on unproven therapies and add considerably to the costs of health care,” he said.

“Widespread consumption of Chinese herbals of unknown efficacy and potential toxicity will jeopardize the health of unsuspecting consumers worldwide.”

Global norm?

Details about traditional medicine will be included in the 11th version of the WHO’s global compendium, known as the International Statistical Classification of Diseases and Related Health Problems, or ICD, for the first time.

It’s an important document that categorizes thousands of diseases and medical diagnoses, influences how research is conducted and can be used to determine insurance coverage.

WHO said the “purpose of the ICD is to capture information on all health conditions and their treatment — the reason for including traditional medicine conditions and practices is that it is used by hundreds of thousands of people worldwide.”

While traditional medicine originated in ancient China, today it’s widely used throughout Asia, including in Japan and Korea, and it took the WHO more than a decade to get representatives from Asian countries to condense thousands of years of knowledge into one neat classification system.

Tarik Jasarevic, a spokesman for WHO, said traditional medicine diagnosis is poorly documented or not documented, and its inclusion in the ICD will “link traditional medicine practices with global norms and standard development.”

However, he added the inclusion of traditional medicine was “not an endorsement of the scientific validity of any Traditional Medicine practice or the efficacy of any Traditional Medicine intervention.”

Huge win

Chinese leaders have been lobbying for the move. For them, it’s a huge win and the push has come right from the top: When President Xi Jinping visited WHO headquarters for the first time in Geneva in 2017, he brought along a bronze statue showing acupuncture marks on the body.

The country has been promoting TCM on the world stage, both as away to burnish its global image and influence, and for a slice of a growing market internationally. In China, TCM is worth $130 billion, according to the country’s State Administration of Traditional Chinese Medicine.

The country’s 2016 “strategic plan” on the Development of Traditional Chinese Medicine supports the expansion of Chinese medicine overseas and advocates the use of Beijing’s Belt and Road global economic initiative to promote TCM.

But WHO’s move has left some scientists perplexed.

The effectiveness of Chinese medicine is in most cases unproven, and only a few herbs have been tested systematically for toxicity or carcinogenicity in the same way Western medicines are in the United States and Europe, said Grollman.

In his research, Grollman looked at Aristolochia plants that have long been used for medical purposes and found they can cause cancer and kidney failure.

“Empirical knowledge based on tradition should not be permitted to “trump” the scientific method in matters of public health,” he wrote in 2016 in the journal EMBO.

David Colquhoun, a professor of pharmacology at University College London, said that the evidence that any form of traditional medicine works is “negligible.”